166
Participants
Start Date
January 11, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
February 1, 2027
Basimglurant
"Period 1: Basimglurant 1.5 to 3.5 mg QD titrated on individual tolerability.~Period 2: Patients randomized to receive either double blind Basimglurant at the tolerated dose from Period 1 or Placebo.~OLE: Open label Basimglurant at the dose tolerated from Period 2, patients previously assigned placebo in period to be titrated to the Period 1."
Placebo
Participant randomized to receive matching placebo once daily.
Danish Headache Center (Site #: 1201), Glostrup Municipality
Columbia University - Irving Medical Center (Site #: 1008), New York
Uludag University Faculty of Medicine Hospital (Site #: 9001), Bursa
Fondazione IRCCS Di Rilievo Nazionale Istituto Nazionale Neurologico Carlo Besta (Site #: 1804), Milan
Hospital Universitario Fundacion Jimenez Diaz (Site #: 1903), Madrid
Hospital Universitario La Paz - PPDS (Site #: 1907), Madrid
Vista Clinical Research,LLC (Site#: 1010), Newnan
Mersin University Faculty of Medicine Hospital (Site #: 9007), Mersin
University of South Florida (Site #: 1002), Tampa
Istanbul University Istanbul Medical Faculty Hospital (Site #: 9003), Istanbul
Bagcilar Medipol Mega University Hospital (Site #: 9002), Istanbul
Kocaeli University Faculty of Medicine Hospital (Site #: 9004), Kocaeli
Hospital Universitario Virgen del Rocio - PPDS (Site #: 1904), Seville
Selcuk University Medical Faculty (Site #: 9006), Selçuklu
University of Cincinnati (Site #: 1007), Cincinnati
Hospital Clinico Universitario de Valencia (Site #: 1906), Valencia
Azienda Ospedaliera Universitaria Careggi (Site #: 1806), Florence
Universitätsklinikum Bonn (Site #: 1707), Bonn
Duzce University Health Application and Research Center (9008), Düzce
Kaizen Brain Center (Site #: 1001), La Jolla
L & A Morales Healthcare INC (Site#: 1011), Miami
Beth Israel Deaconess Medical Center (Site #: 1004), Boston
Altea Research - Nevada - ClinEdge - PPDS (Site #1006), Las Vegas
Università Campus Bio Medico Di Roma (Site #: 1805), Rome
IRCCS San Raffaele Pisana (Site #: 1801), Rome
La Sapienza-Università di Roma-Policlinico Umberto I (Site #: 1802), Rome
Niepubliczny Zaklad Opieki Zdrowotnej (NZOZ) Zespo (Site #: 2602), Dąbrowa Górnicza
Centrum Medyczne Linden (Site #: 2605), Krakow
FutureMeds - Lodzi - PPDS (Site #: 2606), Lodz
Prywatny Gabinet Lekarski U. Chyrchel-Paszkiewicz (Site #: 2604), Lublin
MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak (Site #: 2601), Wroclaw
Afyon Kocatepe University Faculty of Medicine (Site #: 9005), Afyonkarahisar
St. Thomas' Hospital (Site #: 2504), London
St Pancras Clinical Research (Site #: 2503), London
Lead Sponsor
Noema Pharma AG
INDUSTRY